Allogene Therapeutics (ALLO) Amortizatization of Intangibles (2018 - 2026)

Allogene Therapeutics has disclosed Amortizatization of Intangibles across 9 years of filings, most recently posting $885000.0 for Q1 2026.

• Amortizatization of Intangibles for Q1 2026 came in at $885000.0, down 32.24% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.8 million (down 44.58% YoY), and the FY2025 annual result was $4.2 million, down 49.44% from the prior year.
• Amortizatization of Intangibles came in at $885000.0 for Q1 2026 at Allogene Therapeutics, up from $821000.0 in the prior quarter.
• In the past five years, Amortizatization of Intangibles ranged from a high of $3.3 million in Q4 2023 to a low of -$1.3 million in Q1 2022.
• The 5-year median for Amortizatization of Intangibles is $1.1 million (2023), against an average of $1.0 million.
• Across the five-year window, Amortizatization of Intangibles surged 2214.74% in 2023 and sank 53.31% in 2025, its largest moves.
• Allogene Therapeutics' Amortizatization of Intangibles stood at -$156000.0 in 2022, then soared by 2214.74% to $3.3 million in 2023, then sank by 49.95% to $1.7 million in 2024, then sank by 50.27% to $821000.0 in 2025, then climbed by 7.8% to $885000.0 in 2026.
• The last three Amortizatization of Intangibles figures came in at $885000.0 (Q1 2026), $821000.0 (Q4 2025), and $923000.0 (Q3 2025), per Business Quant data.